Skip to main content
Caplight Logo









Uresta

Uresta

Private
Shediac, New BrunswickHealthcare & Life Scienceshttps://uresta.com/

Last Round

Seed

Mar 26, 2025

Total Funding Raised

$5.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Uresta is a therapeutic devices company that manufactures and sells a reusable, over-the-counter bladder support device designed to help women manage stress urinary incontinence.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

stress urinary incontinenceSUIbladder supportreusable pessaryfemtechincontinence devicebladder leakagewomen's healthover-the-counter devicedirect-to-consumerDTCpelvic floor supportmedical deviceFDA-cleared devicehardware salesB2B2C

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Uresta Comparables

Compare Uresta with similar companies based on industry and business-model similarity.

Uresta comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cntrl+ Inc.
93%
Ovala, Inc.
91%
Watkins-Conti Products, Inc.
86%

Uresta Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 26, 2025

Key People

Founding team and executive leadership

Lauren Barker

CEO & Co-founder

Founding Team

Samuel Imbeault

Chief Operating Officer, Executive Board Member

Executive Team

Uresta Investors

Notable investors and investment history

Uresta investors
InvestorRounds
BDC CapitalSeed
New Brunswick Innovation FoundationSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2026

    Grew 67% QoQ, from 9 to 15 employees.

Recent news

Latest coverage and updates

  • launchesOct 9, 2026

    Uresta launches Uresta 2.0 in New York on Oct 9th '26

Uresta Filings

Explore SEC and related filing metadata, where available.

Uresta filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Uresta's valuation, stock price, and market status.

Is Uresta a public or private company?

Uresta is a private company.

What is the current stock price of Uresta?

Uresta is a private company, so its shares have no public market price. Caplight tracks Uresta's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Uresta worth (valuation)?

Valuation information for Uresta is not publicly available.

Can I buy Uresta stock?

Uresta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Uresta's last funding round?

Uresta's most recent funding round was Seed on March 26, 2025.

Who are the main investors in Uresta?

Key investors in Uresta include BDC Capital.

Will Uresta IPO soon?

No public IPO plans have been announced for Uresta.

How can I track Uresta secondary market activity?

Caplight tracks bids, offers, and trades in Uresta's shares on secondary markets.

Firmographic Details

HeadquartersShediac, New Brunswick
Employee Range9
Year Founded2003
Last FundingMar 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?